MediPharm Labs Corp. (LABS.TO)

CAD 0.06

(-7.69%)

Gross Profit Summary of MediPharm Labs Corp.

MediPharm Labs Corp.'s latest annual gross profit in 2023 was 5.85 Million CAD , up 320.17% from previous year.
MediPharm Labs Corp.'s latest quarterly gross profit in 2024 Q2 was 3.58 Million CAD , up 32.94% from previous quarter.
MediPharm Labs Corp. reported a annual gross profit of -1.91 Million CAD in annual gross profit 2022, up 87.45% from previous year.
MediPharm Labs Corp. reported a annual gross profit of -15.24 Million CAD in annual gross profit 2021, up 65.33% from previous year.
MediPharm Labs Corp. reported a quarterly gross profit of 2.69 Million CAD for 2024 Q1, up 36.8% from previous quarter.
MediPharm Labs Corp. reported a quarterly gross profit of 4.21 Million CAD for 2023 FY, up 320.17% from previous quarter.

Annual Gross Profit Chart of MediPharm Labs Corp. (2023 - 2016)

Historical Annual Gross Profit of MediPharm Labs Corp. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	5.85 Million CAD	320.17%
2022	-1.91 Million CAD	87.45%
2021	-15.24 Million CAD	65.33%
2020	-43.97 Million CAD	-202.48%
2019	42.91 Million CAD	981.77%
2018	3.96 Million CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	3.58 Million CAD	32.94%
2024 Q1	2.69 Million CAD	36.8%
2023 FY	4.21 Million CAD	320.17%
2023 Q4	1.97 Million CAD	-18.37%
2023 Q3	2.41 Million CAD	182.69%
2023 Q2	855 Thousand CAD	120.93%
2023 Q1	387 Thousand CAD	83.41%
2022 Q1	-403 Thousand CAD	91.9%
2022 FY	-1.91 Million CAD	87.45%
2022 Q4	211 Thousand CAD	117.73%
2022 Q3	-1.19 Million CAD	-123.68%
2022 Q2	-532 Thousand CAD	-32.01%
2021 FY	-15.24 Million CAD	65.33%
2021 Q4	-4.97 Million CAD	-167.37%
2021 Q3	-1.86 Million CAD	75.95%
2021 Q2	-7.73 Million CAD	-1037.21%
2021 Q1	-680 Thousand CAD	97.25%
2020 Q3	-10.58 Million CAD	-578.66%
2020 Q2	2.21 Million CAD	120.33%
2020 Q1	-10.88 Million CAD	-208.97%
2020 FY	-43.97 Million CAD	-202.48%
2020 Q4	-24.72 Million CAD	-133.49%
2019 FY	42.91 Million CAD	981.77%
2019 Q3	14.75 Million CAD	30.44%
2019 Q2	11.31 Million CAD	64.84%
2019 Q1	6.86 Million CAD	92.11%
2019 Q4	9.98 Million CAD	-32.32%
2018 Q4	3.57 Million CAD	0.0%
2018 Q2	- CAD	100.0%
2018 Q1	-179.41 Thousand CAD	0.0%
2018 FY	3.96 Million CAD	0.0%
2018 Q3	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 Q4	- CAD	0.0%
2016 FY	- CAD	0.0%

Peer Gross Profit Comparison of MediPharm Labs Corp.

Name	Gross Profit	Gross Profit Difference
Aurora Cannabis Inc.	131.46 Million CAD	95.546%
Avicanna Inc.	6.65 Million CAD	12.07%
Avant Brands Inc.	12.43 Million CAD	52.904%
Cardiol Therapeutics Inc.	-248.35 Thousand CAD	2457.512%
Crescita Therapeutics Inc.	10.36 Million CAD	43.506%
Knight Therapeutics Inc.	152.65 Million CAD	96.164%
OrganiGram Holdings Inc.	35.07 Million CAD	83.306%
Canopy Growth Corporation	80.88 Million CAD	92.761%
Willow Biosciences Inc.	-659 Thousand CAD	988.467%
Auxly Cannabis Group Inc.	21.27 Million CAD	72.482%